National

DR Congo confirms more than 6,000 Ebola cases, almost 3,000 deaths

Sep 01, 2026

Nairobi [Kenya], September 1: More than 6,000 people have contracted the Ebola virus in the Democratic Republic of the Congo in the current outbreak, and 2,911 of them have died, the Information Ministry reported in Kinshasa on Monday.
Experts believe there is a high number of unreported cases. At present, 619 people are reported to be in isolation or receiving treatment.
The current outbreak of the Bundibugyo strain of the disease has been particularly difficult to contain, partly because there is so far neither a specific vaccine nor a specific treatment. The World Health Organization (WHO) announced the outbreak in mid-May. Given the already high number of cases at the time, experts believe that the first Ebola infections may have occurred undetected as early as February.
The north-eastern province of Ituri was initially affected. Cases have now been reported in six provinces of Africa's second-largest country by area. Clinical trials of two antiviral treatments have been under way since early July. In addition, a clinical trial involving the Ervebo vaccine began last week. Ervebo is approved for the more common Zaire strain of the virus.
According to the Africa Centres for Disease Control and Prevention, suspicions that the Bundibugyo strain may have mutated have not been confirmed.
Source: Qatar Tribune

More news

Infosys: Differentiated AI strategy and a sharp focus on value unlock propels 29% sequential growth in AI revenues

Bengaluru (Karnataka) [India], October 23: Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), a global leader in AI-first business consulting and technology services, delivered $5,145 million in Q2 revenues, year on year growth of 1.5% and sequential growth of 1.2% in constant currency. Operating margin was stable at 21.0%. EPS growth was 8.7% year on year in rupee terms. TCV of large deal wins was $5.2 billion, with 62% net new. Robust Q2 large deal TCV at $5.2 billion with 62% net new; lays solid foundation for future growth. FY 27 revenue guidance revised to 1%-2% and margin guidance retained at 20%-22%.

Oct 23, 2026